Biogen

Biogen is a leading biotechnology company founded in 1978, specializing in pioneering innovative science to develop new medicines for various diseases. The company focuses on advancing first-in-class treatments and therapies, with a strong emphasis on research and development. Biogen operates globally, with headquarters in Cambridge, Massachusetts, and international offices in Switzerland. The company is known for its contributions to treatments for multiple sclerosis, Alzheimer’s disease, rare diseases, and lupus, among others. Biogen also engages in community partnerships, educational initiatives, and advocacy for patient care.